logo
  • Home
  • News
Menu

Moderna’s COVID-19 vaccine is granted authorization in Australia

Home / Stock Analysis / Moderna’s COVID-19 vaccine is granted authorization in Australia
Article feature image

Moderna’s COVID-19 vaccine is granted authorization in Australia

09 Aug Stock Analysis

Shares of Moderna Inc.
MRNA,
+10.63%
were up 9.4% in trading on Monday after the company said its COVID-19 vaccine has been granted a provisional authorization in Australia to adults who are at least 18 years old. Australia has purchased 10 million doses…

Click here to view the original article.

Tags:
Global, MarketWatch
Facebook Google+ Twitter Pinterest
  Previous
Next  

Related Posts

Mask-Group-67_1764126265239_1764126272024.jpg
+

Excelsoft Technologies share price LIVE Updates: Stock slips below listing price; should you buy, sell or hold?

26 Nov Stock Analysis
Adani_enterprises_rights_issue_1764126670400_1764126670569.JPG
+

Adani Enterprises rights issue opens: Price, entitlement ratio, other important details in 10 points

26 Nov Stock Analysis

recent post

  • 69269aeaf0cbed7f46117046_69269ae9f703437a4c886508_lastImage.png

    The Future of Crypto: Investment Trends

    Nov 26 2025
  • Mask-Group-67_1764126265239_1764126272024.jpg

    Excelsoft Technologies share price LIVE Updates:

    Nov 26 2025
  • 69267d8f68dfc54415d89836_69267d8ec28911738bc4ebd6_lastImage.png

    What’s Ark Invest’s Game Plan in

    Nov 26 2025
  • Adani_enterprises_rights_issue_1764126670400_1764126670569.JPG

    Adani Enterprises rights issue opens: Price,

    Nov 26 2025
  • 6926808a09ac6576a356476d_69268089364a5abdb119b430_lastImage.png

    What’s Next for Crypto Trading in

    Nov 26 2025

Categories

  • Business
  • Crypto News
  • Investing Strategy
  • People
  • Stock Analysis

©2019.  All Rights Reserved.